Comparative effectiveness of corticosteroid injections for trigger finger: A systematic review of randomized controlled trials
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026
DOI: 10.1016/j.bjps.2025.11.047 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026. Verfasst von Gabriel Kuper und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of British Columbia, 317 - 2194 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada. Electronic address: gnkuper@stud…. Hauptthemen laut MEDLINE: Methylprednisolone, Trigger Finger Disorder, Triamcinolone, Glucocorticoids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Trigger finger is a common condition marked by painful catching or locking of a digit during motion. Although corticosteroid injections (CSIs) are widely used, there is limited consensus on the optimal corticosteroid type, dose, injection technique, or use of adjunctive therapies. This systematic review examined the effectiveness and safety of methylprednisolone and triamcinolone in achieving symptom remission. METHODS: A systematic search was conducted across PubMed, Embase, and MEDLINE from inception to May 2024. Inclusion criteria focused on randomized controlled trials (RCTs) evaluating methylprednisolone or triamcinolone in adults with trigger finger. The primary outcome was symptom remission, defined as the resolution of triggering and functional impairment. Data extraction and risk-of-bias assessments were performed in duplicate using the Revised Cochrane Risk-of-Bias Tool. RESULTS: Thirteen RCTs, including 1116 patients (1153 digits), were analyzed. Methylprednisolone showed higher overall remission (83.6%) than triamcinolone (44.8%), with consistent efficacy across doses and techniques. Although higher doses of triamcinolone improved outcomes, a statistically significant dose-response relationship was not found. Injection technique (ultrasound-guided vs blind; intra-sheath vs extra-sheath) did not significantly influence outcomes. Secondary injections improved outcomes in partial responders. Adverse events occurred in 2.8% of triamcinolone patients (e.g., skin atrophy, steroid flare) and were not reported for methylprednisolone. CONCLUSION: Methylprednisolone appeared more effective and better tolerated than triamcinolone in trigger finger treatment. Injection technique and adjunctive therapies, such as splinting, had a limited impact on outcomes. Further research is needed to tailor treatment to individual patient characteristics. Systematic review Level I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of British Columbia, 317 - 2194 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada. Electronic address: gnkuper@student.ubc.ca.
- Faculty of Medicine, University of British Columbia, 317 - 2194 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
- Division of Plastic Surgery, Department of Surgery, 2775 Laurel Street, 11th Floor, Vancouver, BC V5Z 1M9, Canada.
Zitieren
APA
Kuper, G., Da Silva, D., Carr, M., & Brown, E. (2026). Comparative effectiveness of corticosteroid injections for trigger finger: A systematic review of randomized controlled trials. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2025.11.047
Vancouver
Kuper G, Da Silva D, Carr M, Brown E. Comparative effectiveness of corticosteroid injections for trigger finger: A systematic review of randomized controlled trials. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026. doi:10.1016/j.bjps.2025.11.047
BibTeX
@article{Kuper2026,
author = {Kuper, Gabriel and Da Silva, Dylan and Carr, Matthew and Brown, Erin},
title = {Comparative effectiveness of corticosteroid injections for trigger finger: A systematic review of randomized controlled trials},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2026},
doi = {10.1016/j.bjps.2025.11.047}
}
EUVIMED